09/05/2024 6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 4:33 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:28 PM | Nurix Therapeutics (Subject) Ring Christine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 5:23 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 4:41 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:24 PM | Nurix Therapeutics (Subject) Ring Christine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:25 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/01/2024 6:06 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 6:06 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 3:31 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 6:06 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 6:06 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 6:06 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 3:06 PM | Kunkel Lori Anne (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:45 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
07/01/2024 5:35 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 2:23 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:39 PM | Nurix Therapeutics (Issuer) Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 6:30 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 12:30 PM | BlackRock Inc. (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
06/05/2024 5:01 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 5:36 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 6:06 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 6:25 PM | Nurix Therapeutics (Issuer) Saltzman Edward C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:25 PM | Nurix Therapeutics (Issuer) Reinsdorf Judith A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:25 PM | Lacey David L. (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:25 PM | GREGORY JULIA P (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:26 PM | Kunkel Lori Anne (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:26 PM | Nurix Therapeutics (Issuer) Silva Paul M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 5:01 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:19 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 5:33 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:33 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:33 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 4:10 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/12/2024 4:12 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 3:06 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/10/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 6:06 AM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024 12:17 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad) The stock market collapsed and didn't recover for an entire decade.
And what we're facing today could be even worse.
That's why the actions you take in the next 90 days could be crucial for your financial future. Take these 4 steps today to protect your retirement NOW |
03/27/2024 6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 6:20 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:22 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 3:51 PM | Nurix Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024 6:22 AM | Nurix Therapeutics (Issuer) SANDS ARTHUR T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:51 AM | Deep Track Capital, LP (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 7:00 AM | Nurix Therapeutics (Subject) SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024 12:47 PM | MORGAN STANLEY (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024 12:56 PM | Nurix Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
01/30/2024 5:52 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:52 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:53 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024 9:28 AM | Nurix Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:19 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:55 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 11:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:40 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:40 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:41 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:03 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |